Novo Nordisk

Which drugmakers have the healthiest presence on social media?
Medical Marketing and Media
Wed, 09/28/16 - 10:40 am
social media
Eli Lilly
JNJ
Boehringer Ingelheim
Novo Nordisk
Novo Shows Its Devotion To Tresiba's Cause
Seeking Alpha
Wed, 09/28/16 - 10:20 am
Novo Nordisk
diabetes
insulin
Tresiba
Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Yahoo/Reuters
Sat, 09/17/16 - 01:16 pm
Novo Nordisk
semaglutide
diabetes
Novo pulls 71,000 kits of glucagon med from US market
BioPharma Dive
Thu, 09/15/16 - 07:20 pm
Novo Nordisk
recalls
glucagon
GlucaGen HypoKit
diabetes
Novo Nordisk faces delay for insulin combo
BioPharma Dive
Tue, 09/6/16 - 11:03 am
Novo Nordisk
diabetes
insulin
IDegLira
Departing Pharma CEOs Leave Waning Sales for Successors to Solve
Bloomberg
Fri, 09/2/16 - 11:27 am
Pharma CEOs
Novo Nordisk
Lars Sorenson
Gilead Sciences
John Martin
Eli Lilly
John Lechleiter
GSK
Andrew Witty
Novo Nordisk chief Lars Rebien Sorensen to step down early as pricing pressures mount
Fierce Pharma
Thu, 09/1/16 - 09:20 am
Novo Nordisk
Lars Sorenson
Novo Nordisk Vs. Oramed - A Second Look At The Battle For Oral Insulin
Seeking Alpha
Mon, 08/22/16 - 10:10 pm
Novo Nordisk
Oramed
insulin
oral insulin
diabetes
NN1953
ORMD-0801
Sanofi can’t even buy a break now, as rival Novo speeds ahead on diabetes showdown
Endpoints
Mon, 08/22/16 - 11:41 am
Sanofi
Novo Nordisk
diabetes
Lantus
Xultophy
The ‘don’t eat me’ antidote: GlaxoSmithKline, Roche and Novo back $86M startup in high-stakes CD47 showdown
Endpoints
Tue, 08/16/16 - 11:16 am
GSK
Roche
Novo Nordisk
Tioma Therapeutics
CD47
immuno-oncology
Novo Nordisk sees pricing challenges "intensifying"
BioPharma Dive
Tue, 08/9/16 - 10:47 pm
Novo Nordisk
drug pricing
Novo's insulin pill shows promise in mid-stage trial
Yahoo/Reuters
Fri, 08/5/16 - 11:32 am
Novo Nordisk
clinical trials
diabetes
insulin
OI338GT
Novo’s Victoza Diabetes Medicine Rebuffed by Express Scripts
Bloomberg
Tue, 08/2/16 - 08:50 am
Novo Nordisk
Express Scripts
Victoza
PBMs
diabetes
Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth
Fierce Pharma
Mon, 07/11/16 - 09:15 am
diabetes
Novo Nordisk
Eli Lilly
GLP-1 agonist
Victoza
Trulicity
The World's 12 Most Reputable Pharmaceutical Companies In 2016
Forbes
Sat, 07/2/16 - 12:28 pm
Bayer
Abbott Labs
Novo Nordisk
Roche
Merck
Could Novo Nordisk’s 2016 Earnings Impress Wall Street?
Marketwatch
Tue, 06/28/16 - 11:06 am
Novo Nordisk
earnings
How Big Is the Diabetes Treatment Market?
Motley Fool
Wed, 06/22/16 - 07:06 pm
diabetes
Eli Lilly
Novo Nordisk
What Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller?
Motley Fool
Mon, 06/20/16 - 10:27 am
Novo Nordisk
diabetes
Victoza
Why This Pharma Giant Lost $8 Billion in Market Cap This Week
Fortune
Fri, 06/17/16 - 10:25 am
Novo Nordisk
Victoza
diabetes
Novo Nordisk Drug Cuts Diabetic Deaths, But Not Enough For Wall Street
Investors.com
Tue, 06/14/16 - 10:04 am
Novo Nordisk
diabetes
Victoza

Pages